Inhibitors and Breakers of Advanced Glycation Endproducts (AGEs): A Review

E-ISSN： 1875-6107|2|2|135-161

ISSN： 1568-0134

Source： Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol.2, Iss.2, 2002-06, pp. : 135-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alternative Routes for the Formation of Immunochemically Distinct Advanced Glycation End-products In Vivo

Current Molecular Medicine, Vol. 1, Iss. 3, 2001-07 ,pp. : 305-315

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor for Advanced Glycation Endproducts (RAGE): A Formidable Force in the Pathogenesis of the Cardiovascular Complications of DiabetesAging

Current Molecular Medicine, Vol. 7, Iss. 8, 2007-12 ,pp. : 699-710

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [ Receptor for Advanced Glycation Endproducts (RAGE): Coming Full Circle in Unraveling the Pathogenesis of Chronic Disease Guest Editor: Ann Marie Schmidt ]

Current Molecular Medicine, Vol. 7, Iss. 8, 2007-12 ,pp. : 697-698

Bentham Science Publishers

Access to resources Recommend Favorite

Immunofluorescence detection of advanced glycation end products (AGEs) in cookies and its correlation with acrylamide content and antioxidant activity

By Tregoat Virginie Brohee Marcel Cordeiro Fernando van Hengel Arjon

Food and Agricultural Immunology, Vol. 20, Iss. 3, 2009-09 ,pp. : 253-268

Taylor & Francis Ltd

Access to resources Recommend Favorite

The role of advanced glycation in the pathogenesis of diabetic retinopathy

By Stitt A.W.

Experimental and Molecular Pathology, Vol. 75, Iss. 1, 2003-08 ,pp. : 95-108

Elsevier

Access to resources Recommend Favorite